Literature DB >> 27403220

Atrial Fibrillation in Patients with Transient Ischemic Attack in Accordance with the Tissue-Based Definition.

Björn Scheef1, Mohamed Al-Khaled2.   

Abstract

BACKGROUND: Transient ischemic attack (TIA) management requires a cardiac evaluation with a Holter electrocardiogram (ECG), preferably a long-term (24 h) electrocardiogram (LT-ECG), to detect atrial fibrillation (AF), which places patients at higher risk of cerebrovascular events. The aim of this study was to determine the frequency of AF using ECG and LT-ECG in patients with tissue-based TIA.
METHODS: During a three-year period (starting in 2011), all consecutive patients with tissue-based TIA (no evidence of infarction by brain imaging) were included and prospectively evaluated.
RESULTS: Of 861 patients (mean age, 70 ± 13 years; 49.7% women), 854 patients (99.2%) had an ECG at admission, and 338 patients (39.3%) underwent 24-h LT-ECG monitoring during hospitalization. Patients who underwent LT-ECG monitoring were significantly younger (68 vs. 71 years; P=0.001) and experienced longer symptom duration (143 vs. 79 minutes; P=0.024) compared with those who did not. Furthermore, they had lower rates of unilateral weakness (32% vs. 39%; P=0.034) and previous strokes (18% vs. 26%; P=0.007). The LT-ECG investigation was also associated with longer hospitalization (7.9 vs. 5.7 days; P<0.001). A total of 77 patients (8.9%) exhibited AF on the ECG at admission. The LT-ECG revealed AF among seven patients (2.1%); five of these received a new treatment with oral anticoagulation based on the LT-ECG findings. Using the logistic regression, the presence of AF was associated with the following: age over 65 years (odds ratio [OR], 20.6; 95% confidence interval [CI], 2.8-152; P=0.003), hypertension (OR, 3.1; 95% CI: 1-8.9; P=0.041) and increased glucose level >6.05 mmol/L) on admission (OR, 1.9; 95% CI: 1-3.5; P=0.036).
CONCLUSION: Cardiac evaluation with LT-ECG appears to increase the rate of detected AF and may lead to a change in secondary prophylaxis in patients with tissue-based TIA.

Entities:  

Keywords:  Atrial fibrillation; TIA; cardioembolism; outcome; stroke; tissue-based definition

Year:  2016        PMID: 27403220      PMCID: PMC4925762     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  18 in total

1.  An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Ralph L Sacco; Scott E Kasner; Joseph P Broderick; Louis R Caplan; J J Buddy Connors; Antonio Culebras; Mitchell S V Elkind; Mary G George; Allen D Hamdan; Randall T Higashida; Brian L Hoh; L Scott Janis; Carlos S Kase; Dawn O Kleindorfer; Jin-Moo Lee; Michael E Moseley; Eric D Peterson; Tanya N Turan; Amy L Valderrama; Harry V Vinters
Journal:  Stroke       Date:  2013-05-07       Impact factor: 7.914

2.  Incidence and short-term prognosis of transient ischemic attack in a population-based study.

Authors:  Dawn Kleindorfer; Peter Panagos; Arthur Pancioli; Jane Khoury; Brett Kissela; Daniel Woo; Alexander Schneider; Kathleen Alwell; Edward Jauch; Rosie Miller; Charles Moomaw; Rakesh Shukla; Joseph P Broderick
Journal:  Stroke       Date:  2005-02-24       Impact factor: 7.914

3.  In-hospital stroke recurrence and stroke after transient ischemic attack: frequency and risk factors.

Authors:  Hebun Erdur; Jan F Scheitz; Martin Ebinger; Andrea Rocco; Ulrike Grittner; Andreas Meisel; Peter M Rothwell; Matthias Endres; Christian H Nolte
Journal:  Stroke       Date:  2015-03-03       Impact factor: 7.914

4.  Short-term prognosis after emergency department diagnosis of TIA.

Authors:  S C Johnston; D R Gress; W S Browner; S Sidney
Journal:  JAMA       Date:  2000-12-13       Impact factor: 56.272

5.  Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm.

Authors:  Raoul Stahrenberg; Mark Weber-Krüger; Joachim Seegers; Frank Edelmann; Rosine Lahno; Beatrice Haase; Meinhard Mende; Janin Wohlfahrt; Pawel Kermer; Dirk Vollmann; Gerd Hasenfuss; Klaus Gröschel; Rolf Wachter
Journal:  Stroke       Date:  2010-10-21       Impact factor: 7.914

6.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

7.  Atrial fibrillation in patients with cryptogenic stroke.

Authors:  David J Gladstone; Melanie Spring; Paul Dorian; Val Panzov; Kevin E Thorpe; Judith Hall; Haris Vaid; Martin O'Donnell; Andreas Laupacis; Robert Côté; Mukul Sharma; John A Blakely; Ashfaq Shuaib; Vladimir Hachinski; Shelagh B Coutts; Demetrios J Sahlas; Phil Teal; Samuel Yip; J David Spence; Brian Buck; Steve Verreault; Leanne K Casaubon; Andrew Penn; Daniel Selchen; Albert Jin; David Howse; Manu Mehdiratta; Karl Boyle; Richard Aviv; Moira K Kapral; Muhammad Mamdani
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

8.  Stroke risk after transient ischemic attack in a population-based setting.

Authors:  Lynda D Lisabeth; Jennifer K Ireland; Jan M H Risser; Devin L Brown; Melinda A Smith; Nelda M Garcia; Lewis B Morgenstern
Journal:  Stroke       Date:  2004-06-10       Impact factor: 7.914

9.  Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack.

Authors:  Denis Jabaudon; Juan Sztajzel; Katia Sievert; Theodor Landis; Roman Sztajzel
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

10.  Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study.

Authors:  Martin Grond; Marek Jauss; Gerhard Hamann; Erwin Stark; Roland Veltkamp; Darius Nabavi; Markus Horn; Christian Weimar; Martin Köhrmann; Rolf Wachter; Ludger Rosin; Paulus Kirchhof
Journal:  Stroke       Date:  2013-10-15       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.